2017 Annual Meeting | PL5 - Frontiers in Neuroscience Plenary Session
| 09:15 AM - 09:35 AM | Speaker |
The Promise of Immunotherapy for Neurodegenerative Disorders: Progress and Challenges
Eliezer Masliah, MD |
| 09:35 AM - 09:55 AM | Speaker |
Genome and Epigenome Editing for Gene Therapy and Cell Programming
Charles Gersbach, PhD |
| 09:55 AM - 10:15 AM | Speaker |
Epilepsy at the Cutting Edge: Using Novel Models for Therapeutic Advances
Amy R. Brooks-Kayal, MD, FAAN |
| 10:15 AM - 10:35 AM | Speaker |
Vesicle Communication in the Tumor-bearing Brain
Xandra O. Breakefield, PhD |
| 10:35 AM - 10:55 AM | Speaker |
The Lives of a Gene: Diverse Roles in Diseases of Developing and Mature Brain
M. Elizabeth Ross, MD, PhD |
| 10:55 AM - 11:15 AM | Speaker |
Axonopathies: What Next?
Mary Reilly, MD, FRCP, FRCPI |
| Amy R. Brooks-Kayal, MD, FAAN | Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Brooks-Kayal has stock in Johnson and Johnson. The institution of Dr. Brooks-Kayal has received research support from NINDS. |
| Mary Reilly, MD, FRCP, FRCPI | The institution of Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alynlam. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AKCEA. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inflectis. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MRC. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from NIH. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MDA. |
| Xandra O. Breakefield, PhD | Dr. Breakefield has nothing to disclose. |
| Charles Gersbach, PhD | No disclosure on file |
| Eliezer Masliah, MD | Dr. Masliah has nothing to disclose. |
| M. Elizabeth Ross, MD, PhD | No disclosure on file |
| Randolph S. Marshall, MD, FAAN | The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |